Johnson & Johnson Inc., a global leader in the healthcare industry, is headquartered in California and operates extensively across North America, Europe, and Asia. Founded in 1886, the company has a rich history marked by innovation and commitment to improving health outcomes. Specialising in pharmaceuticals, medical devices, and consumer health products, Johnson & Johnson is renowned for its diverse portfolio, which includes iconic brands such as Band-Aid, Tylenol, and Neutrogena. Their unique approach to product development focuses on safety and efficacy, setting them apart in a competitive market. With a strong market position, Johnson & Johnson has consistently been recognised for its contributions to healthcare, including numerous awards for corporate responsibility and sustainability. The company's dedication to research and development continues to drive advancements in medical technology and consumer health solutions.
How does Johnson & Johnson Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Johnson & Johnson Inc.'s score of 44 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Johnson & Johnson Inc., headquartered in California, currently does not provide specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Kenvue Inc., which may influence its climate commitments and reporting. As of now, Johnson & Johnson Inc. has not outlined any specific reduction targets or initiatives related to carbon emissions. There are no documented science-based targets (SBTi) or other climate pledges available in the provided data. This lack of detailed emissions data and reduction initiatives suggests that the company may still be in the process of developing its climate strategy or reporting framework. Given the context of the industry, it is essential for companies like Johnson & Johnson Inc. to establish clear climate commitments and reduction targets to align with global sustainability goals. The absence of specific emissions data and reduction initiatives highlights an opportunity for the company to enhance its environmental accountability and transparency.
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 73,841,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 136,832,000 | 000,000,000 | 000,000,000 | - | - |
| Scope 3 | 3,652,178,000 | 0,000,000,000 | 0,000,000,000 | - | - |
Johnson & Johnson Inc.'s Scope 3 emissions, which decreased by 19% last year and decreased by approximately 24% since 2020, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 76% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Johnson & Johnson Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.